These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

256 related items for PubMed ID: 3814832

  • 1. Refractory cytopenias: clinical course according to bone marrow cytology and cellularity.
    Riccardi A, Giordano M, Girino M, Cazzola M, Montecucco CM, Cassano E, Danova M, Ucci G, Castello A, Coci A.
    Blut; 1987 Mar; 54(3):153-63. PubMed ID: 3814832
    [Abstract] [Full Text] [Related]

  • 2. Hypoplastic myelodysplastic syndrome.
    Nand S, Godwin JE.
    Cancer; 1988 Sep 01; 62(5):958-64. PubMed ID: 3409176
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Clinical aspects of the myelodysplastic syndromes (MDS) with special reference to refractory anemia with excess of blasts (RAEB).
    Omine M, Yamauchi H.
    Nihon Ketsueki Gakkai Zasshi; 1989 Jul 01; 52(4):800-10. PubMed ID: 2618556
    [Abstract] [Full Text] [Related]

  • 7. Diagnostic criteria for hypocellular acute leukemia: a clinical entity distinct from overt acute leukemia and myelodysplastic syndrome.
    Nagai K, Kohno T, Chen YX, Tsushima H, Mori H, Nakamura H, Jinnai I, Matsuo T, Kuriyama K, Tomonaga M, Bennett JM.
    Leuk Res; 1996 Jul 01; 20(7):563-74. PubMed ID: 8795690
    [Abstract] [Full Text] [Related]

  • 8. Clinical impact of dysplastic changes in acquired aplastic anemia: A systematic study of bone marrow biopsies in children and adults.
    Marchesi RF, Velloso EDRP, Garanito MP, Leal AM, Siqueira SAC, Azevedo Neto RS, Rocha V, Zerbini MCN.
    Ann Diagn Pathol; 2020 Apr 01; 45():151459. PubMed ID: 32000075
    [Abstract] [Full Text] [Related]

  • 9. Myelodysplastic syndromes. A clinical and pathologic analysis of 109 cases.
    Foucar K, Langdon RM, Armitage JO, Olson DB, Carroll TJ.
    Cancer; 1985 Aug 01; 56(3):553-61. PubMed ID: 3891071
    [Abstract] [Full Text] [Related]

  • 10. Measurement of secondary colony formation after 5 weeks in long-term cultures in patients with myelodysplastic syndrome.
    Sato T, Kim S, Selleri C, Young NS, Maciejewski JP.
    Leukemia; 1998 Aug 01; 12(8):1187-94. PubMed ID: 9697872
    [Abstract] [Full Text] [Related]

  • 11. Life expectancy in primary myelodysplastic syndromes: a prognostic score based upon histopathology from bone marrow biopsies of 569 patients.
    Maschek H, Gutzmer R, Choritz H, Georgii A.
    Eur J Haematol; 1994 Nov 01; 53(5):280-7. PubMed ID: 7813708
    [Abstract] [Full Text] [Related]

  • 12. Diagnostic and prognostic values of in vitro culture growth patterns of marrow granulocyte-macrophage progenitors in patients with myelodysplastic syndrome.
    Shih LY, Chiu WF, Lee CT.
    Leukemia; 1991 Dec 01; 5(12):1092-8. PubMed ID: 1774958
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Responsiveness of bone marrow erythropoietic stem cells (CFU-E and BFU-E) to recombinant human erythropoietin (rh-Ep) in vitro in aplastic anemia and myelodysplastic syndrome.
    Aoki I, Higashi K, Homori M, Chikazawa H, Ishikawa K.
    Am J Hematol; 1990 Sep 01; 35(1):6-12. PubMed ID: 2389770
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Cyclosporin A in myelodysplastic syndrome: a preliminary report.
    Dixit A, Chatterjee T, Mishra P, Choudhary DR, Mahapatra M, Saxena R, Choudhry VP.
    Ann Hematol; 2005 Sep 01; 84(9):565-8. PubMed ID: 15809884
    [Abstract] [Full Text] [Related]

  • 18. Hypocellular myelodysplastic syndromes (MDS): new proposals.
    Tuzuner N, Cox C, Rowe JM, Watrous D, Bennett JM.
    Br J Haematol; 1995 Nov 01; 91(3):612-7. PubMed ID: 8555063
    [Abstract] [Full Text] [Related]

  • 19. Proposals for the classification of the myelodysplastic syndromes.
    Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DA, Gralnick HR, Sultan C.
    Br J Haematol; 1982 Jun 01; 51(2):189-99. PubMed ID: 6952920
    [Abstract] [Full Text] [Related]

  • 20. CD34/QBEND10 immunostaining in bone marrow biopsies: an additional parameter for the diagnosis and classification of myelodysplastic syndromes.
    Baur AS, Meugé-Moraw C, Schmidt PM, Parlier V, Jotterand M, Delacrétaz F.
    Eur J Haematol; 2000 Feb 01; 64(2):71-9. PubMed ID: 10997326
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.